The Intelligent Evaluation System of Chest CT for COVID-19, developed by YITU 
under the guidance of Shanghai Public Health Clinical Center, was officially 
launched and was put into the first-line battle against COVID-19 pandemic on 
Jan. 28. It is the first AI-equipped diagnostic assistant, which significantly 
improves efficiency in identifying coronavirus through automatic detection and 
quantitative analysis within 2-3 seconds, and eases the burden of Chinese 
doctors.

YITU Healthcare reinforced its R&D capability with multi-departments 
cooperation right after the outbreak of the pandemic and released its 
cutting-edge AI diagnosis system, with upgrades on a daily basis during the 
Chinese New Year. YITU assisted many designated medical institutions and 
supported the frontline heroes fighting the pandemic.

According to its official public account of Shanghai Public Health Clinical 
Center, one of the authoritative institutions in the field of infectious 
diseases in China and the key unit for the treatment of COVID-19 in Shanghai, 
an article titled "AI Aids the Scientific Prevention and Control, Intelligent 
Evaluation System for COVID-19 Launched in Shanghai Public Health Clinical 
Center", announced its latest achievements in using artificial intelligence 
technology to help doctors carry out quantitative analysis and evaluation of 
therapeutic efficacy of new coronavirus lesions based on CT images.

COVID-19 Diagnosis and Treatment Plan (Trial Version 7) issued by the General 
Office of the National Health Commission of the People's Republic of China 
stipulates that CT imaging results should be used as one of the criteria for 
the diagnosis of COVID-19 nationwide. At the same time, based on clinical 
experience, the CT imaging performance of COVID-19 is further clarified and the 
quantitative evaluation of CT images is incorporated into the clinical 
classification basis.

YITU's AI-driven solution of intelligent diagnosis and quantitative evaluation 
of CT images of COVID-19, are through industry-leading image algorithms, and 
grade the severity of various pneumonia diseases of local lesions, diffuse 
lesions, and whole lung involvement. Furthermore, it accurately quantifies the 
cumulative pneumonia load of the disease through quantitative and omics 
analysis of key image features such as the morphology, range, and density of 
the lesion, and achieves a dynamic 4D contrast of the lung lesions on the CT, 
helping in clinical judgment of the condition, evaluation of the efficacy, and 
prediction of the prognosis.

Taking up the challenge and responsibility in response to frontline needs and 
requests, YITU's Intelligent Evaluation System of Chest CT for COVID-19 has 
been adopted across 25 provinces and municipal autonomous prefectures in 100 
medical institutions and served over 100,000 person-times in China by far.

Source: YITU Technology